Show simple item record

dc.contributores-ES
dc.creatorMassardo, Teresa; Sección Medicina Nuclear, Departamento de Medicina, Hospital Clínico Universidad de Chile
dc.creatorJofre, María Josefina; Centro PET de Imágenes Moleculares, Hospital Militar de Santiago, HOSMIL Chile.
dc.creatorSierralta, María Paulina; Centro PET de Imágenes Moleculares, Hospital Militar de Santiago, HOSMIL Chile.
dc.creatorCanessa, José; Servicio de Medicina Nuclear, Hospital Dirección de Previsión de Carabineros de Chile, DIPRECA
dc.creatorCastro, Gabriel; Sección Medicina Nuclear, Departamento de Medicina, Hospital Clínico Universidad de Chile
dc.creatorBerrocal, Isabel; Sección Medicina Nuclear, Departamento de Medicina, Hospital Clínico Universidad de Chile
dc.creatorGallegos, Iván; Departamento Anatomía Patológica, Hospital Clínico Universidad de Chile
dc.date2012-08-31
dc.date.accessioned2019-11-11T18:28:17Z
dc.date.available2019-11-11T18:28:17Z
dc.identifierhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/view/1908
dc.identifier.urihttps://revistaschilenas.uchile.cl/handle/2250/111517
dc.descriptionPOSITRON EMISSION TOMOGRAPHY WITH FLUORINE-DEOXYGLUCOSE IN SARCOMAS AND NON-SARCOMA NON-EPITHELIAL TUMORS. Background: The usefulness of positron emission tomography (PET) with fluorine-deoxyglucose (FDG) in sarcomas and non-sarcoma non-epithelial (NSNE) tumors is not clearly defined Aim: To report a Chilean experience with NSNE tumors evaluated using PET with FDG. Material and methods: Retrospective review of the database of a PET laboratory. Demographic data, indications and metabolic findings were compared with conventional imaging in 88 adults and children with diverse bone and soft tissue sarcomas as well as 24 gastrointestinal stromal tumors (GIST), 6 pleural malignant mesotheliomas in adults, and 9 medulloblastomas in children. Results: FDG showed good concordance with conventional imaging in NSNE tumors. It was helpful for staging, restaging, follow-up after treatment and for the detection of new not previously suspected lesions. Conclusions: PET with FDG could have a prognostic role and help in patient management, mainly in musculoskeletal and high grade or less differentiated sarcomas. In GIST, it was a good tool for immunotherapy control. es-ES
dc.languagees
dc.publisherRevista Médica de Chilees-ES
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/1908/4696
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/1908/4697
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/1908/4698
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/1908/4699
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/1908/5539
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/1908/5540
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/1908/5541
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/1908/5542
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/1908/5543
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/1908/5544
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/1908/5545
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/1908/6206
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/1908/6207
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/1908/6288
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/1908/7446
dc.sourceRevista Médica de Chile; Vol. 140, núm. 9 (2012): SEPTIEMBRE 2012es-ES
dc.source0034-9887
dc.subjectNeoplasms; Positron-emission Tomography; Sarcomaes-ES
dc.titleUtilidad del estudio PET con FDG en la evaluación de sarcomas de diverso origen y de tumores no-sarcomas no epiteliales (NSNE)es-ES
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typees-ES


This item appears in the following Collection(s)

Show simple item record